CY1108498T1 - Συνθεση εμβολιου η οποια περιεχει ως εκδοχο μια αλκυλφωσφατιδυλοχολινη - Google Patents
Συνθεση εμβολιου η οποια περιεχει ως εκδοχο μια αλκυλφωσφατιδυλοχολινηInfo
- Publication number
- CY1108498T1 CY1108498T1 CY081101283T CY081101283T CY1108498T1 CY 1108498 T1 CY1108498 T1 CY 1108498T1 CY 081101283 T CY081101283 T CY 081101283T CY 081101283 T CY081101283 T CY 081101283T CY 1108498 T1 CY1108498 T1 CY 1108498T1
- Authority
- CY
- Cyprus
- Prior art keywords
- composition containing
- vaccine composition
- pharmaceutical composition
- additionally contains
- phosphatidyl choline
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αναφέρεται σε μια φαρμακευτική σύνθεση η οποία περιέχει ένα τουλάχιστον αντιγόνο εμβολίου, η οποία χαρακτηρίζεται από το ότι περιέχει επιπλέον ένα τουλάχιστον παράγωγο φωσφορικού εστέρα της φωσφατιδυλοχολίνης που έχει τον συντακτικό τύπο (τύπο Ι) στον οποίο το R1 είναι κατώτερο αλκύλιο, τα R2 και R3 είναι ίδια ή διαφορετικά, και μπορούν το καθένα να αντιπροσωπεύει ευθείες αλυσίδες υδρογονανθράκων που έχουν 13 έως 21 άτομα άνθρακα.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0313406A FR2862306B1 (fr) | 2003-11-17 | 2003-11-17 | Composition vaccinale |
EP04805451A EP1696954B1 (fr) | 2003-11-17 | 2004-11-15 | Composition vaccinale adjuvantée par une alkylphosphatidylcholine |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108498T1 true CY1108498T1 (el) | 2014-04-09 |
Family
ID=34508504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY081101283T CY1108498T1 (el) | 2003-11-17 | 2008-11-11 | Συνθεση εμβολιου η οποια περιεχει ως εκδοχο μια αλκυλφωσφατιδυλοχολινη |
Country Status (23)
Country | Link |
---|---|
US (2) | US7344720B2 (el) |
EP (1) | EP1696954B1 (el) |
JP (1) | JP4638880B2 (el) |
KR (1) | KR101136107B1 (el) |
CN (1) | CN1882358B (el) |
AT (1) | ATE412429T1 (el) |
AU (1) | AU2004290943B2 (el) |
BR (1) | BRPI0416670A (el) |
CA (1) | CA2545086C (el) |
CY (1) | CY1108498T1 (el) |
DE (1) | DE602004017504D1 (el) |
DK (1) | DK1696954T3 (el) |
ES (1) | ES2311875T3 (el) |
FR (1) | FR2862306B1 (el) |
IL (1) | IL175573A (el) |
LT (1) | LT5435B (el) |
LV (1) | LV13457B (el) |
NO (1) | NO20062779L (el) |
PL (1) | PL1696954T3 (el) |
PT (1) | PT1696954E (el) |
SI (1) | SI1696954T1 (el) |
WO (1) | WO2005049080A1 (el) |
ZA (1) | ZA200603522B (el) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100752990B1 (ko) * | 2006-08-02 | 2007-08-30 | 주식회사 대웅 | 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물 |
TWI444384B (zh) * | 2008-02-20 | 2014-07-11 | Gilead Sciences Inc | 核苷酸類似物及其在治療惡性腫瘤上的用途 |
MX2010008799A (es) | 2008-03-05 | 2010-09-07 | Sanofi Pasteur | Proceso para estabilizar una composicion de vacuna que contiene adyuvante. |
NZ597007A (en) | 2009-05-14 | 2013-09-27 | Sanofi Pasteur | Meningococcus vaccine containing lipooligosaccharide (los) from modified strains of l6 immunotype neisseria meningitidis |
AU2010247253A1 (en) * | 2009-05-14 | 2012-01-12 | Sanofi Pasteur | Method for detoxification of lipopolysaccharide (LPS) or of lipid a of gram-negative bacteria |
AU2010247252A1 (en) | 2009-05-14 | 2012-01-12 | Sanofi Pasteur | Method for admixing the lipopolysaccharide (LPS) of gram-negative bacteria |
EP2578974A1 (en) | 2011-10-05 | 2013-04-10 | Sanofi Pasteur Sa | Process line for the production of freeze-dried particles |
JP5761143B2 (ja) * | 2011-11-02 | 2015-08-12 | 株式会社リコー | 撮像ユニット、撮像ユニットを搭載した車両 |
US20140147475A1 (en) * | 2012-11-29 | 2014-05-29 | Antonius Arnoldus Christiaan Jacobs | Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida |
WO2014147001A1 (en) | 2013-03-18 | 2014-09-25 | Intervet International B.V. | Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica |
CA2955562C (en) | 2014-07-21 | 2018-05-22 | Thomas Gebhard | Liquid feeding device for the generation of droplets |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6100064A (en) | 1984-04-06 | 2000-08-08 | Chiron Corporation | Secreted viral proteins useful for vaccines and diagnostics |
FR2773156B1 (fr) | 1997-12-26 | 2000-03-31 | Biovacs Inc | Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida |
CN1468089B (zh) | 2000-09-28 | 2011-09-21 | 诺华疫苗和诊断公司 | 用于传送异源核酸的微粒体 |
JP4164361B2 (ja) * | 2000-11-07 | 2008-10-15 | イムノワクチン テクノロジーズ インコーポレーテッド | 増強した免疫応答を有するワクチン、およびその調製方法 |
US7303881B2 (en) * | 2004-04-30 | 2007-12-04 | Pds Biotechnology Corporation | Antigen delivery compositions and methods of use |
-
2003
- 2003-11-17 FR FR0313406A patent/FR2862306B1/fr not_active Expired - Fee Related
-
2004
- 2004-11-15 AU AU2004290943A patent/AU2004290943B2/en not_active Ceased
- 2004-11-15 DK DK04805451T patent/DK1696954T3/da active
- 2004-11-15 JP JP2006540508A patent/JP4638880B2/ja not_active Expired - Fee Related
- 2004-11-15 CN CN2004800338756A patent/CN1882358B/zh not_active Expired - Fee Related
- 2004-11-15 ZA ZA200603522A patent/ZA200603522B/en unknown
- 2004-11-15 WO PCT/FR2004/002911 patent/WO2005049080A1/fr active IP Right Grant
- 2004-11-15 DE DE200460017504 patent/DE602004017504D1/de active Active
- 2004-11-15 SI SI200430990T patent/SI1696954T1/sl unknown
- 2004-11-15 US US10/989,154 patent/US7344720B2/en not_active Expired - Fee Related
- 2004-11-15 EP EP04805451A patent/EP1696954B1/fr active Active
- 2004-11-15 PL PL04805451T patent/PL1696954T3/pl unknown
- 2004-11-15 BR BRPI0416670 patent/BRPI0416670A/pt not_active IP Right Cessation
- 2004-11-15 KR KR1020067009520A patent/KR101136107B1/ko active IP Right Grant
- 2004-11-15 AT AT04805451T patent/ATE412429T1/de active
- 2004-11-15 PT PT04805451T patent/PT1696954E/pt unknown
- 2004-11-15 ES ES04805451T patent/ES2311875T3/es active Active
- 2004-11-15 CA CA 2545086 patent/CA2545086C/en not_active Expired - Fee Related
-
2006
- 2006-05-11 IL IL175573A patent/IL175573A/en active IP Right Grant
- 2006-05-15 LV LVP-06-70A patent/LV13457B/lv unknown
- 2006-05-17 LT LT2006036A patent/LT5435B/lt not_active IP Right Cessation
- 2006-06-14 NO NO20062779A patent/NO20062779L/no not_active Application Discontinuation
-
2008
- 2008-01-09 US US11/971,751 patent/US7767658B2/en not_active Expired - Fee Related
- 2008-11-11 CY CY081101283T patent/CY1108498T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108498T1 (el) | Συνθεση εμβολιου η οποια περιεχει ως εκδοχο μια αλκυλφωσφατιδυλοχολινη | |
CY1108823T1 (el) | Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3 | |
CY1115719T1 (el) | Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων | |
BR0010555A (pt) | Inibidores de neuraminidases | |
EA200501098A1 (ru) | Антибактериальные агенты | |
CY1108295T1 (el) | Παραγωγα μονοσακχαριτη αβερμεκτινης τα οποια εχουν παρασιτοκτονες ιδιοτητες | |
CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
RU2009106934A (ru) | Производное аминофосфата и модулятор рецептора s1p, содержащий его в качестве активного ингредиента | |
CY1113873T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
CY1111022T1 (el) | Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων | |
CY1110694T1 (el) | Μεθοδος παρασκευης παραγωγων της εχινοκανδινης | |
ATE299871T1 (de) | Neue zyklische depsipeptid pf1022 derivate | |
ES2186550B2 (es) | Nuevos derivados de oxazolidinonas como antibacterianos. | |
ECSP045396A (es) | Proceso para preparar derivados de 6-alquiliden penem | |
ES2169242T3 (es) | 2-amino-benzoxazinonas para el tratamiento de infecciones virales. | |
EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
ES2162916T3 (es) | Derivados de acido pirimidin- o triazincarboxilico para el empleo como medicamentos. | |
BRPI0406824A (pt) | Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm | |
ECSP045397A (es) | 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS | |
RU2009111262A (ru) | Лечение микобактериальных инфекций циклипостинами | |
ECSP045405A (es) | Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa | |
SE0002739D0 (sv) | New use | |
PT1280812E (pt) | Ciclipostinas, processo para a sua preparacao e sua utilizacao | |
CY1106576T1 (el) | Υποκατεστημενα παραγωγα 2-πυρρολιδιν-2-υλ-1h-ινδολης για τη θεραπεια ημικρανιας | |
EA200000374A2 (ru) | Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции |